Fisher JL - Search Results

1

Multiparameter precursor analysis of T-cell responses to antigen.

Bercovici N, Givan AL, Waugh MG, Fisher JL, Vernel-Pauillac F, Ernstoff MS, Abastado JP, Wallace PK. Bercovici N, et al. Among authors: fisher jl. J Immunol Methods. 2003 May 1;276(1-2):5-17. doi: 10.1016/s0022-1759(03)00059-0. J Immunol Methods. 2003. PMID: 12738355

2

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens.

Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK. Givan AL, et al. Among authors: fisher jl. J Immunol Methods. 1999 Nov 19;230(1-2):99-112. doi: 10.1016/s0022-1759(99)00136-2. J Immunol Methods. 1999. PMID: 10594357 Free article.

3

Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications.

Guyre CA, Fisher JL, Waugh MG, Wallace PK, Tretter CG, Ernstoff MS, Barth RJ Jr. Guyre CA, et al. Among authors: fisher jl. J Immunol Methods. 2002 Apr 1;262(1-2):85-94. doi: 10.1016/s0022-1759(02)00015-7. J Immunol Methods. 2002. PMID: 11983221

4

Use of cell-tracking dyes to determine proliferation precursor frequencies of antigen-specific T cells.

Givan AL, Fisher JL, Waugh MG, Bercovici N, Wallace PK. Givan AL, et al. Among authors: fisher jl. Methods Mol Biol. 2004;263:109-24. doi: 10.1385/1-59259-773-4:109. Methods Mol Biol. 2004. PMID: 14976363

5

Dye dilution proliferation assay: application of the DDPA to identify tumor-specific T cell precursor frequencies in clinical trials.

Schwaab T, Fisher JL, Meehan KR, Fadul CE, Givan AL, Ernstoff MS. Schwaab T, et al. Among authors: fisher jl. Immunol Invest. 2007;36(5-6):649-64. doi: 10.1080/08820130701674760. Immunol Invest. 2007. PMID: 18161523

6

Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution.

Wallace PK, Tario JD Jr, Fisher JL, Wallace SS, Ernstoff MS, Muirhead KA. Wallace PK, et al. Among authors: fisher jl. Cytometry A. 2008 Nov;73(11):1019-34. doi: 10.1002/cyto.a.20619. Cytometry A. 2008. PMID: 18785636 Free article.

7

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo.

Wallace PK, Kaufman PA, Lewis LD, Keler T, Givan AL, Fisher JL, Waugh MG, Wahner AE, Guyre PM, Fanger MW, Ernstoff MS. Wallace PK, et al. Among authors: fisher jl. J Immunol Methods. 2001 Feb 1;248(1-2):167-82. doi: 10.1016/s0022-1759(00)00350-1. J Immunol Methods. 2001. PMID: 11223077 Clinical Trial.

8

Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu.

Lewis LD, Cole BF, Wallace PK, Fisher JL, Waugh M, Guyre PM, Fanger MW, Curnow RT, Kaufman PA, Ernstoff MS. Lewis LD, et al. Among authors: fisher jl. J Immunol Methods. 2001 Feb 1;248(1-2):149-65. doi: 10.1016/s0022-1759(00)00355-0. J Immunol Methods. 2001. PMID: 11223076 Clinical Trial.

9

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma.

Huarte E, Fisher J, Turk MJ, Mellinger D, Foster C, Wolf B, Meehan KR, Fadul CE, Ernstoff MS. Huarte E, et al. Cancer Lett. 2009 Nov 18;285(1):80-8. doi: 10.1016/j.canlet.2009.05.003. Epub 2009 Jun 6. Cancer Lett. 2009. PMID: 19501956 Free PMC article.

10

Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo.

Wrzesinski SH, Fisher JL, Ernstoff MS. Wrzesinski SH, et al. Among authors: fisher jl. Exp Hematol Oncol. 2013 Mar 9;2(1):8. doi: 10.1186/2162-3619-2-8. Exp Hematol Oncol. 2013. PMID: 23497451 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page